Acadia Pharmaceuticals Inc

Frazier Life Sciences Management, L.P. ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,297,198

Value ($000)

34,648

Weight

0.9%

2022 Q3 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	34,648	0.9%	1,297,198	12/31/2025
2025 Q3	11/14/2025	13,099	0.4%	613,837	9/30/2025
2025 Q1	5/15/2025	7,812	0.4%	470,338	3/31/2025
2024 Q4	2/18/2025	8,631	0.4%	470,338	12/31/2024
2024 Q3	11/15/2024	7,234	0.3%	470,338	9/30/2024
2024 Q2	8/15/2024	7,643	0.4%	470,338	6/30/2024
2024 Q1	5/15/2024	8,697	0.4%	470,338	3/31/2024
2023 Q4	2/14/2024	22,885	1.2%	730,917	12/31/2023
2023 Q3	11/14/2023	13,148	0.9%	630,897	9/30/2023
2023 Q2	8/14/2023	20,533	1.2%	857,338	6/30/2023
2023 Q1	5/15/2023	16,135	1.2%	857,338	3/31/2023
2022 Q4	2/7/2023	13,649	0.8%	857,338	12/31/2022
2022 Q3	11/14/2022	14,026	1.1%	857,338	9/30/2022